1. Home
  2.  » 
  3. About Us
  4.  » 
  5. Our Leadership
  6.  » David Schaffer, Ph.D.
David Schaffer, Ph.D.

Professor Schaffer serves as Director of the Berkeley Stem Cell Center, in addition to holding a position as a professor of chemical and biomolecular engineering, bioengineering, and neuroscience at University of California, Berkeley. He completed his bachelor’s at Stanford University, before undertaking his doctorate at the Massachusetts Institute of Technology, and postdoctoral training at the Salk Institute. His research at Berkeley applies engineering principles to enhance gene therapy and stem cell approaches to treat human disease.

He is the co-founder of three companies: 4D Molecular Therapeutics, Inc., which uses a novel technology platform to engineer optimized, proprietary adeno-associated viral (AAV) vectors for gene therapy; Ignite Immunotherapies, Inc., which is developing novel oncolytic virus technologies as cancer therapies in partnership with Pfizer; and Valitor, Inc., which is developing a novel protein-polymer conjugation technology to develop greatly enhanced protein biologics for a range of disease targets.